The Penicillins and Streptomycins dosage market size in Malaysia per capita increased steadily from 2013 to 2023, reaching $1.87 in 2023. The year-on-year growth was consistent, especially in 2022-2023, showing a 6.25% increase. Over the past five years, the market exhibited a compound annual growth rate (CAGR) of approximately 7.16%, suggesting a robust and consistent increase in per capita market value.
Future trends to watch for include potential shifts towards more advanced antibiotic treatments, the impact of increasing antibiotic resistance, and regulatory changes that could influence market dynamics. The sustained growth trend may continue if these factors are managed effectively.
| # | 31 Countries | US Dollars Per Capita | Last Year | |||
|---|---|---|---|---|---|---|
| 1 | 1 Italy | 11.76 | 2023 | View data | ||
| 2 | 2 New Zealand | 11.59 | 2023 | View data | ||
| 3 | 3 France | 11.21 | 2023 | View data | ||
| 4 | 4 Belgium | 11.17 | 2023 | View data | ||
| 5 | 5 United Kingdom | 10.77 | 2023 | View data | ||
| 23 | 23 Moldova | 2.19 | 2023 | View data | ||
| 24 | 24 Brazil | 2.01 | 2023 | View data | ||
| 25 | 25 Malaysia | 1.87 | 2023 | |||
| 26 | 26 Armenia | 1.75 | 2023 | View data | ||
| 27 | 27 Kyrgyzstan | 1.57 | 2023 | View data | ||
